Justyna Kelly
Chief Operating Officer at POINT Biopharma, Inc. (United States)
Profile
Justyna Kelly is currently the VP-Medical Isotope Development & Operations at POINT Biopharma, Inc. She was previously the Chief Operating Officer at POINT Biopharma Global, Inc. from 2021 to 2023.
Ms. Kelly received her undergraduate and graduate degrees from McMaster University.
Justyna Kelly active positions
Companies | Position | Start |
---|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Chief Operating Officer | - |
Former positions of Justyna Kelly
Companies | Position | End |
---|---|---|
POIT BIOP | Chief Operating Officer | 27/12/2023 |
Training of Justyna Kelly
McMaster University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
POIT BIOP | Health Technology |
Private companies | 1 |
---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Stock Market
- Insiders
- Justyna Kelly